首页> Pharmacoepidemiology and drug safety> Analysis of factors related to the occurrence of important drug-specific postmarketing safety-related regulatory actions: A cohort study focused on first-in-class drugs

Analysis of factors related to the occurrence of important drug-specific postmarketing safety-related regulatory actions: A cohort study focused on first-in-class drugs

导出原文传递

翻译打印收藏纠错

第一作者： Ikeda, Junji

作者： Ikeda, Junji ^[1] ; Kaneko, Masayuki ; Narukawa, Mamoru

作者单位： Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Tokyo, Japan ^[1]

关键词 adverse drug reaction first-in-class pharmacoepidemiology safety-related regulatory action US Food and Drug Administration

发布时间 2020-08-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmacoepidemiology and drug safety

2018年27卷12期

1393-1401页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Pharmacoepidemiology and drug safety

2018年27卷12期

1393-1401页

检索历史清除

Analysis of factors related to the occurrence of important drug-specific postmarketing safety-related regulatory actions: A cohort study focused on first-in-class drugs

Pharmacoepidemiology and drug safety

相似文献

同项目论文

Pharmacoepidemiology and drug safety

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Analysis of factors related to the occurrence of important drug-specific postmarketing safety-related regulatory actions: A cohort study focused on first-in-class drugs

Pharmacoepidemiology and drug safety

相似文献

同项目论文

Pharmacoepidemiology and drug safety

相关期刊

检索历史清除